ROYAL BANK OF CANADA

Bank

Position in CGON — CG Oncology, Inc.

CIK 1000275 TORONTO, A6

Position in CGON

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$898,142

+$123,951 QoQ

Shares Held

12,641

+10.5% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#126

of 226 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 95% Shared 0% None 5%

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,724 across 427 Biotechnology names. CGON ranks #61 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	6,182,479	$490,208,754
2	VRTX	Vertex Pharmaceuticals Inc / Ma	980,259	$486,924,048
3	ALNY	Alnylam Pharmaceuticals, Inc.	875,859	$263,659,830
4	INCY	Incyte Corp	1,132,050	$128,329,182
5	REGN	Regeneron Pharmaceuticals, Inc.	174,515	$108,817,078
6	MRNA	Moderna, Inc.	944,457	$66,140,319
7	INSM	INSMED Inc	416,487	$44,405,840
8	HALO	Halozyme Therapeutics, Inc.	545,761	$42,716,712

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$898,142	12,641	+10.5%	Shares	Defined	2026-08-14
2026-03-31	$774,191	11,439	+18.6%	Shares	Defined	2026-05-15
2025-12-31	$400,500	9,646	-95.4%	Shares	Defined	2026-02-17
2025-09-30	$8,378,722	208,012	+713.4%	Shares	Defined	2025-11-14
2025-06-30	$664,898	25,573	+8122.8%	Shares	Defined	2025-11-21
2025-03-31	$7,615	311	-90.2%	Shares	Defined	2025-11-21
2024-12-31	$91,259	3,182	-43.3%	Shares	Defined	2025-02-14
2024-09-30	$211,890	5,616	+156.6%	Shares	Defined	2024-11-14
2024-06-30	$69,106	2,189	+314.6%	Shares	Sole	2024-11-06
2024-03-31	$23,178	528	—	Shares	Defined	2024-11-05
No filing history on record for this holder in this stock.